A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 10, 2017

Primary Completion Date

February 7, 2018

Study Completion Date

February 7, 2018

Conditions

Dermatitis, Atopic

Interventions

DRUG

KHK4083

IV administration

Trial Locations (1)

Closed information, Sapporo

All Listed Sponsors

lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT03096223 - A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter